UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors

Annals of oncology, 2019-07, Vol.30 (7), p.1134-1142

2019

Volltextzugriff (PDF)

Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers

Nature communications, 2018-09, Vol.9 (1), p.3931-13, Article 3931

2018

Volltextzugriff (PDF)

Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines

Oral oncology, 2013-09, Vol.49 (9), p.872-877

2013

Volltextzugriff (PDF)

Phase Ib study of safety and tolerability of selinexor in Asian patients with advanced solid cancers

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii141

2018

Volltextzugriff (PDF)

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)

Investigational new drugs, 2015-08, Vol.33 (4), p.985-991

2015

Volltextzugriff (PDF)

Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies

Annals of oncology, 2011-11, Vol.22 (11), p.2516-2522

2011

Volltextzugriff (PDF)

Translational aspects of genetic factors in the prediction of drug response variability: a case study of warfarin pharmacogenomics in a multi-ethnic cohort from Asia

The pharmacogenomics journal, 2012-08, Vol.12 (4), p.312-318

2012

Volltextzugriff (PDF)

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients

Annals of oncology, 2003-03, Vol.14 (3), p.449-454

2003

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of docetaxel with or without ketoconazole modulation in chemonaive breast cancer patients

Annals of oncology, 2010-11, Vol.21 (11), p.2175-2182

2010

Volltextzugriff (PDF)

Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies

Annals of oncology, 2015-05, Vol.26 (5), p.998-1005

2015

Volltextzugriff (PDF)

Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy

Annals of oncology, 2011-08, Vol.22 (8), p.1748-1754

2011

Volltextzugriff (PDF)

Expression profile of mRNAs encoding core circadian regulatory proteins in human subcutaneous adipose tissue: correlation with age and body mass index

International Journal of Obesity, 2009-09, Vol.33 (9), p.971-977

2009

Volltextzugriff (PDF)

Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression

Annals of oncology, 2006-11, Vol.17 (11), p.1625-1630

2006

Volltextzugriff (PDF)

A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)

Annals of oncology, 2016-12, Vol.27 (12), p.2210-2215

2016

Volltextzugriff (PDF)

Biophysical cues enhance myogenesis of human adipose derived stem/stromal cells

Biochemical and biophysical research communications, 2013-08, Vol.438 (1), p.180-185

2013

Volltextzugriff (PDF)

Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients

Breast cancer research and treatment, 2014-02, Vol.144 (1), p.143-152

2014

Volltextzugriff (PDF)

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer

Annals of oncology, 2006-07, Vol.17 (7), p.1128-1133

2006

Volltextzugriff (PDF)

Ovariectomy and genes encoding core circadian regulatory proteins in murine bone

Osteoporosis international, 2011-05, Vol.22 (5), p.1633-1639

2011

Volltextzugriff (PDF)

Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia

Clinical genetics, 2005-08, Vol.68 (2), p.137-145

2005

Volltextzugriff (PDF)

Phase I investigator’s perceptions to ‘supersized seamless trials in oncology

Annals of oncology, 2018-11, Vol.29, p.ix26-ix26

2018

Volltextzugriff (PDF)

A rapid and sensitive liquid chromatography/tandem mass spectrometry method for determination of docetaxel in human plasma

Rapid communications in mass spectrometry, 2003-01, Vol.17 (14), p.1548-1552

2003

Volltextzugriff (PDF)

An Evaluation of the Drug Interaction Potential of Pazopanib, an Oral Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, Using a Modified Cooperstown 5+1 Cocktail in Patients With Advanced Solid Tumors

Clinical pharmacology and therapeutics, 2010-11, Vol.88 (5), p.652-659

2010

Volltextzugriff (PDF)

Clinical outcome and prognostic factors for patients treated in a phase I study at the National University Cancer Institute, Singapore (NCIS)

Annals of oncology, 2017-11, Vol.28, p.x40-x40

2017

Volltextzugriff (PDF)

A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)

Annals of oncology, 2018-02, Vol.29 (2), p.526-526

2018

Volltextzugriff (PDF)

Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma

Annals of oncology, 2006-07, Vol.17 (7), p.1152-1157

2006

Volltextzugriff (PDF)

1 – 25 von 327

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(283)
Mit Volltextzugriff
(299)

Publikationsform

Sprache

Englisch
(326)
Italienisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors

Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers

Consensus recommendations for management of head and neck cancer in Asian countries: A review of international guidelines

Phase Ib study of safety and tolerability of selinexor in Asian patients with advanced solid cancers

Multicenter phase II study of the AKT inhibitor MK-2206 in recurrent or metastatic nasopharyngeal carcinoma from patients in the mayo phase II consortium and the cancer therapeutics research group (MC1079)

Phase I and pharmacodynamic study of an orally administered novel inhibitor of histone deacetylases, SB939, in patients with refractory solid malignancies

Translational aspects of genetic factors in the prediction of drug response variability: a case study of warfarin pharmacogenomics in a multi-ethnic cohort from Asia

Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: a phase II study in Caucasian and Asian patients

Pharmacokinetics and pharmacodynamics of docetaxel with or without ketoconazole modulation in chemonaive breast cancer patients

Phase I and biomarker study of OPB-51602, a novel signal transducer and activator of transcription (STAT) 3 inhibitor, in patients with refractory solid malignancies

Serial changes in the expression of breast cancer-related proteins in response to neoadjuvant chemotherapy

Expression profile of mRNAs encoding core circadian regulatory proteins in human subcutaneous adipose tissue: correlation with age and body mass index

Celecoxib reduces microvessel density in patients treated with nasopharyngeal carcinoma and induces changes in gene expression

A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)

Biophysical cues enhance myogenesis of human adipose derived stem/stromal cells

Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients

A multicentre randomised phase II study of carboplatin in combination with gemcitabine at standard rate or fixed dose rate infusion in patients with advanced stage non-small-cell lung cancer

Ovariectomy and genes encoding core circadian regulatory proteins in murine bone

Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia

Phase I investigator’s perceptions to ‘supersized seamless trials in oncology

A rapid and sensitive liquid chromatography/tandem mass spectrometry method for determination of docetaxel in human plasma

An Evaluation of the Drug Interaction Potential of Pazopanib, an Oral Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, Using a Modified Cooperstown 5+1 Cocktail in Patients With Advanced Solid Tumors

Clinical outcome and prognostic factors for patients treated in a phase I study at the National University Cancer Institute, Singapore (NCIS)

A phase Ib study of selumetinib (AZD6244, ARRY-142886) in combination with sorafenib in advanced hepatocellular carcinoma (HCC)

Paclitaxel, 5-fluorouracil and hydroxyurea concurrent with radiation in locally advanced nasopharyngeal carcinoma

Suchergebnisse filtern